Will this work? We'll see....

One of the most recent design puzzles posted is a human fibronectin
structure (from PDB: 1FNF). It is an all-beta protein that is commonly used
as a scaffold for making antibody mimetics. The reason for using
fibronectin is that it does not contain the disulfides commonly found in
antibodies, and is stable in reducing conditions. Most importantly they can
be produced in large quantities in E. coli. A collaborator of ours takes
advantage of these properties, using fibronectin to host a variety of loops
on its surface and panning for desirable properties in a selection
experiment. It has been observed, however, that the stability of
fibronectin sometimes is drastically reduced when their loops connecting the
strands are replaced with non-native ones, as in engineering fibronectin to bind a particular target.
A considerable amount of protein (and therefore the diversity one can screen)
can be lost due to this. An ideal scenario would be to have an extremely
stable scaffold for which the stability is independent of the binding loops,
therefore the experiments are really testing the properties of the loops.
Just to draw an analogy, imagine you are testing the sharpness of knifes,
but the handles on them randomly fail so when you cannot drive a particular
blade through an object, you never know whether it was sufficiently sharp.

We put out this fibronectin puzzle to see if players can pack the core more
tightly, and in the end we chose a single structure produced by the FoldIt
community for experimental testing. It was the design done by BootsMcGraw.
It was chosen because the model showed very promising traits, with few
holes in the core and is scored relatively well. The top ranking structures
sometimes have an excessively abundant aromatic residues, so we did not try
those. To validate the design before it goes into production (which is
time-consuming, and costly, by the way), we sent the sequence through our
structure prediction algorithm via BOINC, and interestingly it found a
funnel near the native structure (the starting structure in this case).
When compared to the funnel generated with the native sequence found on the
crystal structure, they are quite similar! (see figure) Our collaborator at USC has
agreed to test this out in the lab. We'll soon know if this first-ever
experimentally tested design from FoldIT has an improved stability.

Design: BootsMcGraw, Texas.
BOINC: Firas Khatib, Baker Lab, UW.
Experiment: Terry Takahashi, Roberts Lab, USC.

( Posted by  possu 69 1797  |  Fri, 10/16/2009 - 21:49  |  6 comments )
Joined: 04/13/2009
Groups: Contenders
Go Boots!

Go Boots!

Susanne's picture
User offline. Last seen 6 years 26 weeks ago. Offline
Joined: 11/09/2008
Groups: SETI.Germany

Congrats, Boots, well done :)

Joined: 12/06/2008
Groups: Contenders

OMG! I am tickled to death to have contributed to this discovery.

[adjusts stetson for publicity photo]

I hope this new protein does what y'all hope it will.

Joined: 12/06/2008
Groups: Contenders
Which puzzle?

Admins: I am curious... which puzzle was this?

possu's picture
User offline. Last seen 11 years 49 weeks ago. Offline
Joined: 11/16/2007
Groups: None
puzzle 178

It's puzzle 178. Maybe it is not THAT recent....

We'll hopefully get results in a few weeks.

Joined: 05/03/2009
Groups: Contenders
:D As someone may have mentioned...

That, is, fantastic. Boots ya big star...

It may have already been mentioned but I cant wait to see Boots McGraw in the author list if this gets published on MedLine. I remember Polly Matzinger included her pets as authors...

Nice one Boots

User login
Download links:
  Windows    OSX    Linux  
(10.12 or later)

Are you new to Foldit? Click here.

Are you a student? Click here.

Are you an educator? Click here.
Social Media

Only search fold.it
Other Games: Mozak
Recommend Foldit
Top New Users

Developed by: UW Center for Game Science, UW Institute for Protein Design, Northeastern University, Vanderbilt University Meiler Lab, UC Davis
Supported by: DARPA, NSF, NIH, HHMI, Amazon, Microsoft, Adobe, Boehringer Ingelheim, RosettaCommons